Discover
NNNN
Anbio Biotechnology Class A Ordinary Shares
10.08
1 x 10.04
1 x 10.41
bid
ask
-
0.11
1.08%
01:34 PM
timesize
| Ytd | -66.48% | |
| 1y | -78.57% |
9.82
day range
10.64
8.30
52 week range
54.95
| Open | 10.64 | Prev Close | 10.19 | Low | 9.82 | High | 10.64 | Mkt Cap | 442.42M |
| Vol | 17.52K | Avg Vol | 41.34K | EPS | 0.07 | P/E | 145.66 | Forward P/E | N/A |
| Beta | 5.40 | Short Ratio | 1.79 | Inst. Own | 4.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 14.37 | 200-d Avg | 23.72 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 43.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.77M | ||
| Cash and Equivalents (USD) | 7.77M | ||
| Investments | 4.13M | ||
| Investments Current | 4.13M | ||
| Trade and Non-Trade Receivables | 3.66M | ||
| Current Assets | 30.24M | ||
| Total Assets | 30.24M | ||
| Current Liabilities | 87.84K | ||
| Total Liabilities | 87.84K | ||
| Accumulated Retained Earnings (Deficit) | 23.58M | ||
| Shareholders Equity | 30.16M | ||
| Shareholders Equity (USD) | 30.16M | ||